{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:25:38Z","timestamp":1791588338425,"version":"4.3.4"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dietary compounds in cancer prevention have gained significant consideration as a viable method. Indole-3-carbinol (I3C) and 3,3\u2032-diindolylmethane (DIM) are heterocyclic and bioactive chemicals found in cruciferous vegetables like broccoli, cauliflower, cabbage, and brussels sprouts. They are synthesized after glycolysis from the glucosinolate structure. Clinical and preclinical trials have evaluated the pharmacokinetic\/pharmacodynamic, effectiveness, antioxidant, cancer-preventing (cervical dysplasia, prostate cancer, breast cancer), and anti-tumor activities of I3C and DIM involved with polyphenolic derivatives created in the digestion showing promising results. However, the exact mechanism by which they exert anti-cancer and apoptosis-inducing properties has yet to be entirely understood. Via this study, we update the existing knowledge of the state of anti-cancer investigation concerning I3C and DIM chemicals. We have also summarized; (i) the recent advancements in the use of I3C\/DIM as therapeutic molecules since they represent potentially appealing anti-cancer agents, (ii) the available literature on the I3C and DIM characterization, and the challenges related to pharmacologic properties such as low solubility, and poor bioavailability, (iii) the synthesis and semi-synthetic derivatives, (iv) the mechanism of anti-tumor action in vitro\/in vivo, (v) the action in cellular signaling pathways related to the regulation of apoptosis and anoikis as well as the cell cycle progression and cell proliferation such as peroxisome proliferator-activated receptor and PPAR\u03b3 agonists; SR13668, Akt inhibitor, cyclins regulation, ER-dependent-independent pathways, and their current medical applications, to recognize research opportunities to potentially use these compounds instead chemotherapeutic synthetic drugs.<\/jats:p>","DOI":"10.1186\/s12935-023-03031-4","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T14:01:46Z","timestamp":1693058506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["3,3\u2032-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways"],"prefix":"10.1186","volume":"23","author":[{"given":"Octavio Daniel","family":"Reyes-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Figueroa-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Itzel","family":"Quintas-Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephany Celeste","family":"Guti\u00e9rrez-Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Hern\u00e1ndez-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Romero-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Del Prado-Audelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Alberto","family":"Bernal-Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila I.","family":"Pe\u00f1a-Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lashyn","family":"Kiyekbayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek Arslan","family":"Ate\u015f\u015fahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Goloshvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Leyva-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"key":"3031_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022,\u201c (in eng). CA Cancer J Clin. 01 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","DOI":"10.3322\/caac.21708"},{"key":"3031_CR2","doi-asserted-by":"publisher","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. \u201cGlobal Cancer Incidence and Mortality Rates and Trends\u2013An Update,\u201c (in eng), Cancer Epidemiol Biomarkers Prev, vol.\u00a025, no. 1, pp.\u00a016\u201327, Jan 2016. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0578.","DOI":"10.1158\/1055-9965.EPI-15-0578"},{"issue":"1","key":"3031_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-021-01213-z","volume":"14","author":"L Lin","year":"2021","unstructured":"Lin L, Li Z, Yan L, Liu Y, Yang H, Li H. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019,\u201c (in eng). J Hematol Oncol. 2021;14(1):22. https:\/\/doi.org\/10.1186\/s13045-021-01213-z.","journal-title":"J Hematol Oncol"},{"key":"3031_CR4","doi-asserted-by":"publisher","unstructured":"Wan Y, Li Y, Yan C, Yan M, Tang Z. Indole: A privileged scaffold for the design of anti-cancer agents,\u201c (in eng). Eur J Med Chem. Dec 01 2019;183:111691. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111691.","DOI":"10.1016\/j.ejmech.2019.111691"},{"key":"3031_CR5","doi-asserted-by":"publisher","unstructured":"Wang YQ et al. \u201cIndole-3-carbinol inhibits cell proliferation and induces apoptosis in Hep-2 laryngeal cancer cells,\u201c (in eng), Oncol Rep, vol.\u00a030, no. 1, pp.\u00a0227 \u2013 33, Jul 2013. https:\/\/doi.org\/10.3892\/or.2013.2411.","DOI":"10.3892\/or.2013.2411"},{"key":"3031_CR6","doi-asserted-by":"publisher","unstructured":"Megna BW, Carney PR, Nukaya M, Geiger P, Kennedy GD. Indole-3-carbinol induces tumor cell death: function follows form,\u201c (in eng). J Surg Res. 07 2016;204(1):47\u201354. https:\/\/doi.org\/10.1016\/j.jss.2016.04.021.","DOI":"10.1016\/j.jss.2016.04.021"},{"issue":"1","key":"3031_CR7","doi-asserted-by":"publisher","first-page":"01","DOI":"10.1016\/j.bbcan.2019.188314","volume":"1873","author":"D Anwanwan","year":"2020","unstructured":"Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches,\u201c (in eng). Biochim Biophys Acta Rev Cancer. 2020;1873(1):01. https:\/\/doi.org\/10.1016\/j.bbcan.2019.188314.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7","key":"3031_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2174\/1389450116666150309115922","volume":"16","author":"I Ali","year":"2015","unstructured":"Ali I, Lone MN, Al-Othman ZA, Al-Warthan A, Sanagi MM. Heterocyclic scaffolds: centrality in Anticancer Drug Development,\u201c (in eng). Curr Drug Targets. 2015;16(7):711\u201334. https:\/\/doi.org\/10.2174\/1389450116666150309115922.","journal-title":"Curr Drug Targets"},{"key":"3031_CR9","doi-asserted-by":"publisher","unstructured":"Tantawy MA, Nafie MS, Elmegeed GA, Ali IAI. \u201cAuspicious role of the steroidal heterocyclic derivatives as a platform for anti-cancer drugs,\u201c (in eng), Bioorg Chem, vol.\u00a073, pp.\u00a0128\u2013146, 08 2017. https:\/\/doi.org\/10.1016\/j.bioorg.2017.06.006.","DOI":"10.1016\/j.bioorg.2017.06.006"},{"key":"3031_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0034-1395861","volume":"47","author":"BL Pfeifer","year":"2015","unstructured":"Pfeifer BL, Fahrendorf T. Indole-3-carbinol: a glucosinolate derivative from cruciferous vegetables for prevention and complementary treatment of breast cancer. Dtsch Z f\u00fcr Onkologie. 2015;47:20\u20137. https:\/\/doi.org\/10.1055\/s-0034-1395861.","journal-title":"Dtsch Z f\u00fcr Onkologie"},{"key":"3031_CR11","doi-asserted-by":"publisher","unstructured":"Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives,\u201c (in eng). Cell Cycle. Sep 2005;4(9):1201\u201315. https:\/\/doi.org\/10.4161\/cc.4.9.1993.","DOI":"10.4161\/cc.4.9.1993"},{"key":"3031_CR12","doi-asserted-by":"publisher","unstructured":"Prabhu B, Balakrishnan D, Sundaresan S. Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats,\u201c (in eng). Hum Exp Toxicol. Jun 2016;35(6):685\u201392. https:\/\/doi.org\/10.1177\/0960327115597985.","DOI":"10.1177\/0960327115597985"},{"key":"3031_CR13","doi-asserted-by":"publisher","unstructured":"Williams DE. \u201cIndoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3\u2019-Diindolylmethane,\u201c (in eng), Front Nutr, vol.\u00a08, p.\u00a0734334, 2021. https:\/\/doi.org\/10.3389\/fnut.2021.734334.","DOI":"10.3389\/fnut.2021.734334"},{"key":"3031_CR14","doi-asserted-by":"crossref","unstructured":"Licznerska B, Baer-Dubowska W. \u201cIndole-3-Carbinol and Its Role in Chronic Diseases,\u201c in Anti-inflammatory Nutraceuticals and Chronic Diseases, S. C. Gupta, S. Prasad, and B. B. Aggarwal Eds. Cham: Springer International Publishing, 2016, pp.\u00a0131\u2013154.","DOI":"10.1007\/978-3-319-41334-1_6"},{"key":"3031_CR15","doi-asserted-by":"publisher","unstructured":"Weng JR, Tsai CH, Kulp SK, Chen CS. \u201cIndole-3-carbinol as a chemopreventive and anti-cancer agent,\u201c (in eng), Cancer Lett, vol.\u00a0262, no. 2, pp.\u00a0153 \u2013 63, Apr 18 2008. https:\/\/doi.org\/10.1016\/j.canlet.2008.01.033.","DOI":"10.1016\/j.canlet.2008.01.033"},{"key":"3031_CR16","doi-asserted-by":"publisher","unstructured":"Melo MN, et al. Chitosan and chitosan\/PEG nanoparticles loaded with indole-3-carbinol: Characterization, computational study and potential effect on human bladder cancer cells,\u201c (in eng). Mater Sci Eng C Mater Biol Appl. May 2021;124:112089. https:\/\/doi.org\/10.1016\/j.msec.2021.112089.","DOI":"10.1016\/j.msec.2021.112089"},{"key":"3031_CR17","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1158\/1078-0432.ccr-04-0163","volume":"10","author":"MJ Anderton","year":"2004","unstructured":"Anderton MJ, et al. Pharmacokinetics and tissue Disposition of Indole-3-carbinol and its Acid Condensation Products after oral administration to mice. Clin Cancer Res. 2004;10:5233\u201341. https:\/\/doi.org\/10.1158\/1078-0432.ccr-04-0163.","journal-title":"Clin Cancer Res"},{"key":"3031_CR18","doi-asserted-by":"publisher","unstructured":"Luo Y, Wang TT, Teng Z, Chen P, Sun J, Wang Q. \u201cEncapsulation of indole-3-carbinol and 3,3\u2019-diindolylmethane in zein\/carboxymethyl chitosan nanoparticles with controlled release property and improved stability,\u201c (in eng), Food Chem, vol.\u00a0139, no. 1\u20134, pp.\u00a0224 \u2013 30, Aug 15 2013. https:\/\/doi.org\/10.1016\/j.foodchem.2013.01.113.","DOI":"10.1016\/j.foodchem.2013.01.113"},{"key":"3031_CR19","doi-asserted-by":"publisher","unstructured":"Song JM et al. \u201cIntranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability,\u201c Int J Pharm, vol. 477, no. 1, pp. 96\u2013101, 2014\/12\/30\/ 2014. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.10.018.","DOI":"10.1016\/j.ijpharm.2014.10.018"},{"key":"3031_CR20","doi-asserted-by":"publisher","unstructured":"Murase SK, Aymat M, Calvet A, del Valle LJ, Puiggal\u00ed J. \u201cElectrosprayed poly(butylene succinate) microspheres loaded with indole derivatives: A system with anticancer activity,\u201c Eur Polymer J, vol. 71, pp. 196\u2013209, 2015\/10\/01\/ 2015. https:\/\/doi.org\/10.1016\/j.eurpolymj.2015.07.047.","DOI":"10.1016\/j.eurpolymj.2015.07.047"},{"key":"3031_CR21","unstructured":"Bradlow HL, Zeligs MA. \u201cDiindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments,\u201c (in eng), In Vivo, vol.\u00a024, no. 4, pp.\u00a0387 \u2013 91, 2010."},{"issue":"1","key":"3031_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1878-5085-4-25","volume":"4","author":"M Paltsev","year":"2013","unstructured":"Paltsev M, Kiselev V, Muyzhnek E, Drukh V, Kuznetsov I, Pchelintseva O. Comparative preclinical pharmacokinetics study of 3,3\u2032-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon? EPMA J. 2013;4(1):25. https:\/\/doi.org\/10.1186\/1878-5085-4-25.","journal-title":"EPMA J"},{"key":"3031_CR23","doi-asserted-by":"publisher","unstructured":"Vo QV, Mechler A. \u201cIn Silico Study of the Radical Scavenging Activities of Natural Indole-3-Carbinols,\u201c (in eng), J Chem Inf Model, vol. 60, no. 1, pp. 316\u201321, Jan 27 2020. https:\/\/doi.org\/10.1021\/acs.jcim.9b00917.","DOI":"10.1021\/acs.jcim.9b00917"},{"issue":"12","key":"3031_CR24","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1158\/1055-9965.EPI-06-0396","volume":"15","author":"GA Reed","year":"2006","unstructured":"Reed GA, et al. Single-dose and multiple-dose administration of Indole-3-Carbinol to women: Pharmacokinetics based on 3,3\u2032-Diindolylmethane. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2477\u201381. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0396.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3031_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7324\/JAPS.2015.501112","volume":"5","author":"R Dash","year":"2015","unstructured":"Dash R, et al. In silico analysis of indole-3-carbinol and its metabolite DIM as EGFR tyrosine kinase inhibitors in platinum resistant ovarian cancer vis a vis ADME\/T property analysis. J Appl Pharm Sci. 2015;5:73\u20138.","journal-title":"J Appl Pharm Sci"},{"key":"3031_CR26","doi-asserted-by":"publisher","unstructured":"Prado NJ et al. \u201cAnti-inflammatory, antioxidant, antihypertensive, and antiarrhythmic effect of indole-3-carbinol, a phytochemical derived from cruciferous vegetables,\u201c (in eng), Heliyon, vol.\u00a08, no. 2, p. e08989, Feb 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e08989.","DOI":"10.1016\/j.heliyon.2022.e08989"},{"key":"3031_CR27","doi-asserted-by":"publisher","unstructured":"Ramakrishna K, Singh N, Krishnamurthy S. Diindolylmethane ameliorates platelet aggregation and thrombosis: in silico, in vitro, and in vivo studies (in eng). Eur J Pharmacol. 2022;919:174812. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174812.","DOI":"10.1016\/j.ejphar.2022.174812"},{"key":"3031_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-022-00771-y","author":"K Ramakrishna","year":"2022","unstructured":"Ramakrishna K, Jain SK, Krishnamurthy S. Pharmacokinetic and Pharmacodynamic Properties of Indole-3-carbinol in experimental focal ischemic Injury. Eur J Drug Metab Pharmacokinet. 2022. https:\/\/doi.org\/10.1007\/s13318-022-00771-y.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"3031_CR29","doi-asserted-by":"publisher","unstructured":"Guo Y, et al. Effect of indole-3-carbinol on ethanol-induced liver injury and acetaldehyde-stimulated hepatic stellate cells activation using precision-cut rat liver slices,\u201c (in eng). Clin Exp Pharmacol Physiol. Dec 2010;37(12):1107\u201313. https:\/\/doi.org\/10.1111\/j.1440-1681.2010.05450.x.","DOI":"10.1111\/j.1440-1681.2010.05450.x"},{"key":"3031_CR30","doi-asserted-by":"publisher","unstructured":"Munakarmi S, Chand L, Shin HB, Jang KY, Jeong YJ. Indole-3-Carbinol Derivative DIM Mitigates Carbon Tetrachloride-Induced Acute Liver Injury in Mice by Inhibiting Inflammatory Response, Apoptosis and Regulating Oxidative Stress,\u201c (in eng). Int J Mol Sci. Mar 17 2020;21(6). https:\/\/doi.org\/10.3390\/ijms21062048.","DOI":"10.3390\/ijms21062048"},{"key":"3031_CR31","doi-asserted-by":"publisher","unstructured":"Li N et al. \u201cCruciferous vegetable and isothiocyanate intake and multiple health outcomes,\u201c (in eng), Food Chem, vol.\u00a0375, p.\u00a0131816, May 01 2022. https:\/\/doi.org\/10.1016\/j.foodchem.2021.131816.","DOI":"10.1016\/j.foodchem.2021.131816"},{"key":"3031_CR32","doi-asserted-by":"publisher","first-page":"919484","DOI":"10.3389\/fnut.2022.919484","volume":"9","author":"Q Wang","year":"2022","unstructured":"Wang Q, et al. Higher levels of urinary thiocyanate, a Biomarker of Cruciferous Vegetable Intake, were Associated with Lower Risks of Cardiovascular Disease and all-cause Mortality among non-smoking subjects,\u201c (in eng). Front Nutr. 2022;9:919484. https:\/\/doi.org\/10.3389\/fnut.2022.919484.","journal-title":"Front Nutr"},{"key":"3031_CR33","doi-asserted-by":"publisher","unstructured":"Li YZ et al. \u201cCruciferous vegetable consumption and multiple health outcomes: an umbrella review of 41 systematic reviews and meta-analyses of 303 observational studies,\u201c (in eng), Food Funct, vol.\u00a013, no. 8, pp.\u00a04247\u20134259, Apr 20 2022. https:\/\/doi.org\/10.1039\/d1fo03094a.","DOI":"10.1039\/d1fo03094a"},{"key":"3031_CR34","doi-asserted-by":"publisher","unstructured":"Bosetti C et al. \u201cCruciferous vegetables and cancer risk in a network of case-control studies,\u201c (in eng), Ann Oncol, vol.\u00a023, no. 8, pp.\u00a02198\u20132203, Aug 2012. https:\/\/doi.org\/10.1093\/annonc\/mdr604.","DOI":"10.1093\/annonc\/mdr604"},{"key":"3031_CR35","doi-asserted-by":"publisher","unstructured":"Higdon JV, Delage B, Williams DE, Dashwood RH. \u201cCruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis,\u201c (in eng), Pharmacol Res, vol.\u00a055, no. 3, pp.\u00a0224 \u2013 36, Mar 2007. https:\/\/doi.org\/10.1016\/j.phrs.2007.01.009.","DOI":"10.1016\/j.phrs.2007.01.009"},{"key":"3031_CR36","doi-asserted-by":"publisher","unstructured":"Mori N, et al. Cruciferous Vegetable Intake Is Inversely Associated with Lung Cancer Risk among Current Nonsmoking Men in the Japan Public Health Center (JPHC) Study,\u201c (in eng). J Nutr. May 2017;147(5):841\u20139. https:\/\/doi.org\/10.3945\/jn.117.247494.","DOI":"10.3945\/jn.117.247494"},{"key":"3031_CR37","doi-asserted-by":"publisher","unstructured":"Lampe JW, Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables,\u201c (in eng). J Nutr. Oct 2002;132(10):2991\u20134. https:\/\/doi.org\/10.1093\/jn\/131.10.2991.","DOI":"10.1093\/jn\/131.10.2991"},{"key":"3031_CR38","doi-asserted-by":"publisher","unstructured":"Katz E, Nisani S, Chamovitz DA. \u201cIndole-3-carbinol: a plant hormone combatting cancer,\u201c (in eng), F1000Res, vol.\u00a07, 2018. https:\/\/doi.org\/10.12688\/f1000research.14127.1.","DOI":"10.12688\/f1000research.14127.1"},{"key":"3031_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fnut.2016.00024","volume":"3","author":"FJ Barba","year":"2016","unstructured":"Barba FJ, Nikmaram N, Roohinejad S, Khelfa A, Zhu Z, Koubaa M. Bioavailability of glucosinolates and their Breakdown Products: Impact of Processing,\u201c (in eng). Front Nutr. 2016;3:24. https:\/\/doi.org\/10.3389\/fnut.2016.00024.","journal-title":"Front Nutr"},{"key":"3031_CR40","doi-asserted-by":"publisher","unstructured":"Kamal RM et al. \u201cBeneficial Health Effects of Glucosinolates-Derived Isothiocyanates on Cardiovascular and Neurodegenerative Diseases,\u201c (in eng), Molecules, vol.\u00a027, no. 3, Jan 19 2022. https:\/\/doi.org\/10.3390\/molecules27030624.","DOI":"10.3390\/molecules27030624"},{"key":"3031_CR41","doi-asserted-by":"publisher","unstructured":"Oloyede OO, Wagstaff C, Methven L. \u201cThe Impact of Domestic Cooking Methods on Myrosinase Stability, Glucosinolates and Their Hydrolysis Products in Different Cabbage (\u201c (in eng), Foods, vol.\u00a010, no. 12, Nov 24 2021. https:\/\/doi.org\/10.3390\/foods10122908.","DOI":"10.3390\/foods10122908"},{"key":"3031_CR42","doi-asserted-by":"publisher","unstructured":"Bouranis JA, Beaver LM, Ho E. \u201cMetabolic Fate of Dietary Glucosinolates and Their Metabolites: A Role for the Microbiome,\u201c (in eng), Front Nutr, vol.\u00a08, p.\u00a0748433, 2021. https:\/\/doi.org\/10.3389\/fnut.2021.748433.","DOI":"10.3389\/fnut.2021.748433"},{"key":"3031_CR43","doi-asserted-by":"publisher","unstructured":"Holst B, Williamson G. \u201cA critical review of the bioavailability of glucosinolates and related compounds,\u201c (in eng), Nat Prod Rep, vol.\u00a021, no. 3, pp.\u00a0425 \u2013 47, Jun 2004. https:\/\/doi.org\/10.1039\/b204039p.","DOI":"10.1039\/b204039p"},{"key":"3031_CR44","doi-asserted-by":"publisher","unstructured":"Kim JK, Park SU. \u201cCurrent results on the biological and pharmacological activities of Indole-3-carbinol,\u201c (in eng), EXCLI J, vol.\u00a017, pp.\u00a0181\u2013185, 2018. https:\/\/doi.org\/10.17179\/excli2017-1028.","DOI":"10.17179\/excli2017-1028"},{"key":"3031_CR45","unstructured":"Bonnesen C, Eggleston IM, Hayes JD. \u201cDietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines,\u201c (in eng) Cancer Res, vol. 61, no. 16, pp. 6120\u201330, Aug 15 2001."},{"key":"3031_CR46","doi-asserted-by":"publisher","unstructured":"Wu HT, Lin SH, Chen YH. Inhibition of cell proliferation and in vitro markers of angiogenesis by indole-3-carbinol, a major indole metabolite present in cruciferous vegetables (in eng). J Agric Food Chem. 2005;53(13):5164\u20139. https:\/\/doi.org\/10.1021\/jf050034w.","DOI":"10.1021\/jf050034w"},{"key":"3031_CR47","doi-asserted-by":"publisher","unstructured":"Carlson D, Daxenbichler C, VanEtten C, Kwolek W, Williams P. Glucosinolates in Crucifer vegetables: Broccoli, Brussels Sprouts, Cauliflower, Collards, Kale, Mustard Greens, and Kohlrabi. J Am Soc Hortic Sci. 1987;112(1). https:\/\/doi.org\/10.21273\/JASHS.112.1.173.","DOI":"10.21273\/JASHS.112.1.173"},{"issue":"12","key":"3031_CR48","first-page":"1843","volume":"7","author":"S Kim","year":"2013","unstructured":"Kim S, Uddin M, Park S. Glucosinolate accumulation in three important radish (Raphanus sativus) cultivars. Aust J Crop Sci. 2013;7(12):1843\u20137.","journal-title":"Aust J Crop Sci"},{"key":"3031_CR49","doi-asserted-by":"publisher","unstructured":"Kushad MM, et al. Variation of glucosinolates in vegetable crops of Brassica oleracea,\u201c (in eng). J Agric Food Chem. Apr 1999;47(4):1541\u20138. https:\/\/doi.org\/10.1021\/jf980985s.","DOI":"10.1021\/jf980985s"},{"key":"3031_CR50","doi-asserted-by":"publisher","unstructured":"McNaughton SA, Marks GC. \u201cDevelopment of a food composition database for the estimation of dietary intakes of glucosinolates, the biologically active constituents of cruciferous vegetables,\u201c (in eng), Br J Nutr, vol.\u00a090, no. 3, pp.\u00a0687 \u2013 97, Sep 2003. https:\/\/doi.org\/10.1079\/bjn2003917.","DOI":"10.1079\/bjn2003917"},{"key":"3031_CR51","doi-asserted-by":"publisher","unstructured":"Wermter NS, Rohn S, Hanschen FS. \u201cSeasonal Variation of Glucosinolate Hydrolysis Products in Commercial White and Red Cabbages (\u201c (in eng), Foods, vol.\u00a09, no. 11, Nov 17 2020. https:\/\/doi.org\/10.3390\/foods9111682.","DOI":"10.3390\/foods9111682"},{"issue":"2","key":"3031_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr2855","volume":"13","author":"M De Santi","year":"2011","unstructured":"De Santi M, et al. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21\/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines. Breast Cancer Res. 2011;13(2):1\u201315.","journal-title":"Breast Cancer Res"},{"issue":"16","key":"3031_CR53","doi-asserted-by":"publisher","first-page":"7815","DOI":"10.1158\/0008-5472.CAN-07-0794","volume":"67","author":"J-R Weng","year":"2007","unstructured":"Weng J-R, et al. A potent indole-3-carbinol\u2013derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells. Cancer Res. 2007;67(16):7815\u201324.","journal-title":"Cancer Res"},{"key":"3031_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.molimm.2018.05.024","volume":"101","author":"MF Afzali","year":"2018","unstructured":"Afzali MF, et al. A novel diindolylmethane analog, 1, 1-bis (3\u2019-indolyl)-1-(p-chlorophenyl) methane, inhibits the tumor necrosis factor-induced inflammatory response in primary murine synovial fibroblasts through a Nurr1-dependent mechanism. Mol Immunol. 2018;101:46\u201354.","journal-title":"Mol Immunol"},{"key":"3031_CR55","doi-asserted-by":"publisher","unstructured":"Yoon K, Chen CC, Orr AA, Barreto PN, Tamamis P, Safe S. \u201cActivation of COUP-TFI by a Novel Diindolylmethane Derivative,\u201c (in eng), Cells, vol. 8, no. 3, Mar 07 2019. https:\/\/doi.org\/10.3390\/cells8030220.","DOI":"10.3390\/cells8030220"},{"issue":"2","key":"3031_CR56","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.canlet.2008.04.021","volume":"269","author":"S Safe","year":"2008","unstructured":"Safe S, Papineni S, Chintharlapalli S. Cancer chemotherapy with indole-3-carbinol, bis (3\u2032-indolyl) methane and synthetic analogs. Cancer Lett. 2008;269(2):326\u201338.","journal-title":"Cancer Lett"},{"issue":"10","key":"3031_CR57","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1016\/j.ejmech.2009.05.011","volume":"44","author":"D Maciejewska","year":"2009","unstructured":"Maciejewska D, Rasztawicka M, Wolska I, Anuszewska E, Gruber B. Novel 3,3\u2032-diindolylmethane derivatives: synthesis and cytotoxicity, structural characterization in solid state. Eur J Med Chem. 2009;44(10):4136\u201347.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"3031_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/08905436.2022.2028263","volume":"36","author":"G Toydemir","year":"2022","unstructured":"Toydemir G. Screening of the AhR-and Nrf2-linked transcriptional activities of some cruciferous vegetables and nuts in human intestinal epithelial cells as foods containing endogenous AhR ligand precursors. Food Biotechnol. 2022;36(2):93\u2013112.","journal-title":"Food Biotechnol"},{"issue":"9","key":"3031_CR59","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1016\/j.arabjc.2020.08.002","volume":"13","author":"DE Amare","year":"2020","unstructured":"Amare DE, Bovee TF, Mulder PP, Hamers A, Hoogenboom RL. Acid condensation products of indole-3-carbinol and their in-vitro (anti) estrogenic,(anti) androgenic and aryl hydrocarbon receptor activities. Arab J Chem. 2020;13(9):7199\u2013211.","journal-title":"Arab J Chem"},{"key":"3031_CR60","doi-asserted-by":"crossref","unstructured":"Chang Y-C, Riby J, Chang GH, Peng B, Firestone G, Bjeldanes LF. Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3\u2032-diindolylmethane, a major in vivo product of dietary indole-3-carbinol. Biochem Pharmacol. 1999;58(5):825\u201334.","DOI":"10.1016\/S0006-2952(99)00165-3"},{"issue":"11","key":"3031_CR61","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/mc.20857","volume":"51","author":"I Aronchik","year":"2012","unstructured":"Aronchik I, et al. Target protein interactions of indole-3\u2010carbinol and the highly potent derivative 1\u2010benzyl\u2010I3C with the C\u2010terminal domain of human elastase uncouples cell cycle arrest from apoptotic signaling. Mol Carcinog. 2012;51(11):881\u201394.","journal-title":"Mol Carcinog"},{"key":"3031_CR62","doi-asserted-by":"crossref","unstructured":"Kaushik NK et al. \u201cBiomedical importance of indoles,\u201c Molecules, vol.\u00a018, no. 6, pp.\u00a06620\u20136662, 2013.","DOI":"10.3390\/molecules18066620"},{"key":"3031_CR63","doi-asserted-by":"crossref","unstructured":"Jump SM et al. \u201cN-Alkoxy derivatization of indole-3-carbinol increases the efficacy of the G1 cell cycle arrest and of I3C-specific regulation of cell cycle gene transcription and activity in human breast cancer cells,\u201c Biochemical pharmacology, vol.\u00a075, no. 3, pp.\u00a0713\u2013724, 2008.","DOI":"10.1016\/j.bcp.2007.09.024"},{"key":"3031_CR64","doi-asserted-by":"publisher","unstructured":"Fibigr J, \u0160at\u00ednsk\u00fd D, Havl\u00edkov\u00e1 L, Solich P. \u201cA new method for rapid determination of indole-3-carbinol and its condensation products in nutraceuticals using core-shell column chromatography method,\u201c (in eng), J Pharm Biomed Anal, vol.\u00a0120, pp.\u00a0383 \u2013 90, Feb 20 2016. https:\/\/doi.org\/10.1016\/j.jpba.2015.12.039.","DOI":"10.1016\/j.jpba.2015.12.039"},{"key":"3031_CR65","doi-asserted-by":"publisher","unstructured":"Lee SH, Kim JS, Yamaguchi K, Eling TE, Baek SJ. \u201cIndole-3-carbinol and 3,3\u2019-diindolylmethane induce expression of NAG-1 in a p53-independent manner,\u201c (in eng), Biochem Biophys Res Commun, vol. 328, no. 1, pp. 63 \u2013 9, Mar 04 2005. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.138.","DOI":"10.1016\/j.bbrc.2004.12.138"},{"key":"3031_CR66","doi-asserted-by":"publisher","unstructured":"Jongen WM. \u201cGlucosinolates in Brassica: occurrence and significance as cancer-modulating agents,\u201c (in eng), Proc Nutr Soc, vol.\u00a055, no. 1B, pp.\u00a0433 \u2013 46, Mar 1996. https:\/\/doi.org\/10.1079\/pns19960040.","DOI":"10.1079\/pns19960040"},{"key":"3031_CR67","doi-asserted-by":"publisher","unstructured":"McDanell R, McLean AE, Hanley AB, Heaney RK, Fenwick GR. \u201cChemical and biological properties of indole glucosinolates (glucobrassicins): a review,\u201c (in eng), Food Chem Toxicol, vol.\u00a026, no. 1, pp.\u00a059\u201370, Jan 1988. https:\/\/doi.org\/10.1016\/0278-6915(88)90042-7.","DOI":"10.1016\/0278-6915(88)90042-7"},{"key":"3031_CR68","doi-asserted-by":"publisher","unstructured":"Heaney RK, Fenwick GR. \u201cNatural toxins and protective factors in brassica species, including rapeseed,\u201c (in eng), Nat Toxins, vol.\u00a03, no. 4, pp.\u00a0233-7; discussion 242, 1995. https:\/\/doi.org\/10.1002\/nt.2620030412.","DOI":"10.1002\/nt.2620030412"},{"key":"3031_CR69","doi-asserted-by":"publisher","unstructured":"Program NT. Toxicology studies of indole-3-carbinol in F344\/N rats and B6C3F1\/N mice and toxicology and carcinogenesis studies of indole-3-carbinol in Harlan Sprague Dawley rats and B6C3F1\/N mice (gavage studies),\u201c (in eng). Natl Toxicol Program Tech Rep Ser. no. Jul 2017;584. https:\/\/doi.org\/10.22427\/NTP-TR-584.","DOI":"10.22427\/NTP-TR-584"},{"key":"3031_CR70","doi-asserted-by":"publisher","unstructured":"Beaver LM, Yu TW, Sokolowski EI, Williams DE, Dashwood RH, Ho E. \u201c3,3\u2019-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells,\u201c (in eng), Toxicol Appl Pharmacol, vol.\u00a0263, no. 3, pp.\u00a0345 \u2013 51, Sep 15 2012. https:\/\/doi.org\/10.1016\/j.taap.2012.07.007.","DOI":"10.1016\/j.taap.2012.07.007"},{"key":"3031_CR71","unstructured":"Commission E. \u201cEU Novel food catalogue.\u201c https:\/\/webgate.ec.europa.eu\/fip\/novel_food_catalogue\/ (accessed."},{"key":"3031_CR72","doi-asserted-by":"publisher","unstructured":"Rosen CA, Bryson PC. \u201cIndole-3-carbinol for recurrent respiratory papillomatosis: long-term results,\u201c (in eng), J Voice, vol.\u00a018, no. 2, pp.\u00a0248 \u2013 53, Jun 2004. https:\/\/doi.org\/10.1016\/j.jvoice.2003.05.005.","DOI":"10.1016\/j.jvoice.2003.05.005"},{"key":"3031_CR73","doi-asserted-by":"crossref","unstructured":"Chen D-Z, Qi M, Auborn KJ, J. TH. T. J. o. n. Carter, \u201cIndole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium,\u201c vol.\u00a0131, no. 12, pp.\u00a03294\u20133302, 2001.","DOI":"10.1093\/jn\/131.12.3294"},{"key":"3031_CR74","doi-asserted-by":"crossref","unstructured":"Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LFJN. and cancer, \u201cPilot study: effect of 3,3\u2032-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer,\u201c vol.\u00a050, no. 2, pp.\u00a0161\u2013167, 2004.","DOI":"10.1207\/s15327914nc5002_5"},{"key":"3031_CR75","doi-asserted-by":"publisher","unstructured":"Michnovicz JJ, Bradlow HL. Induction of estradiol metabolism by dietary indole-3-carbinol in humans,\u201c (in eng). J Natl Cancer Inst. Jun 06 1990;82(11):947\u20139. https:\/\/doi.org\/10.1093\/jnci\/82.11.947.","DOI":"10.1093\/jnci\/82.11.947"},{"key":"3031_CR76","doi-asserted-by":"publisher","unstructured":"Singh AA, Patil MP, Kang M-J, Niyonizigiye I, Kim G-D. \u201cBiomedical application of Indole-3-carbinol: A mini-review,\u201c Phytochem Lett, vol. 41, pp. 49\u201354, 2021\/02\/01\/ 2021. https:\/\/doi.org\/10.1016\/j.phytol.2020.09.024.","DOI":"10.1016\/j.phytol.2020.09.024"},{"key":"3031_CR77","unstructured":"U. S. N. L. o. Medicine. \u201cClinicalTrials.gov.\u201c https:\/\/clinicaltrials.gov\/ (accessed."},{"key":"3031_CR78","doi-asserted-by":"crossref","unstructured":"Biersack BJCDR. \u201c3,3\u2019-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs,\u201c vol. 3, no. 4, p. 867, 2020.","DOI":"10.20517\/cdr.2020.53"},{"key":"3031_CR79","doi-asserted-by":"publisher","unstructured":"Fletcher A, Huang H, Yu L, Pham Q, Yu L, Wang TTY. \u201cReversible Toxic Effects of the Dietary Supplement Indole-3-Carbinol in an Immune Compromised Rodent Model: Intestine as the Main Target,\u201c J Diet Supplements, vol. 14, no. 3, pp. 303\u201322, 2017\/05\/04 2017. https:\/\/doi.org\/10.1080\/19390211.2016.1215367.","DOI":"10.1080\/19390211.2016.1215367"},{"key":"3031_CR80","doi-asserted-by":"publisher","unstructured":"Centofanti F, et al. Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicity. Cell Death Discov. 2022;8(1):491. https:\/\/doi.org\/10.1038\/s41420-022-01280-2.","DOI":"10.1038\/s41420-022-01280-2"},{"key":"3031_CR81","doi-asserted-by":"crossref","unstructured":"Chen I, McDougal A, Wang F, Safe SJC. \u201cAryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane,\u201c vol.\u00a019, no. 9, pp.\u00a01631\u20131639, 1998.","DOI":"10.1093\/carcin\/19.9.1631"},{"key":"3031_CR82","doi-asserted-by":"crossref","unstructured":"Nachshon-Kedmi M, Fares FA, Yannai SJTP. Therapeutic activity of 3,3\u2032-diindolylmethane on prostate cancer in an in vivo model. Prostate. 2004;61(2):153\u201360.","DOI":"10.1002\/pros.20092"},{"key":"3031_CR83","doi-asserted-by":"crossref","unstructured":"Kim EJ et al. \u201cOral administration of 3,3\u2032-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB\/c mice,\u201c vol. 139, no. 12, pp. 2373\u20139, 2009.","DOI":"10.3945\/jn.109.111864"},{"key":"3031_CR84","doi-asserted-by":"crossref","unstructured":"Sepkovic DW et al. \u201cDiindolylmethane Inhibits Cervical Dysplasia, Alters Estrogen Metabolism, and Enhances Immune Response in the K14-HPV16 Transgenic Mouse ModelDiindolylmethane Inhibits Cervical Dysplasia in a Mouse Model,\u201c vol. 18, no. 11, pp. 2957\u201364, 2009.","DOI":"10.1158\/1055-9965.EPI-09-0698"},{"key":"3031_CR85","unstructured":"Sepkovic DW et al. \u201c3,3\u2019-Diindolylmethane increases serum interferon-\u03b3 levels in the K14-HPV16 transgenic mouse model for cervical cancer,\u201c vol. 26, no. 2, pp. 207\u201311, 2012."},{"key":"3031_CR86","doi-asserted-by":"publisher","unstructured":"Shilpa G, et al. Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells,\u201c (in eng). Basic Clin Pharmacol Toxicol. Oct 2022;131(4):224\u201340. https:\/\/doi.org\/10.1111\/bcpt.13767.","DOI":"10.1111\/bcpt.13767"},{"key":"3031_CR87","doi-asserted-by":"crossref","unstructured":"Lee S-O, Li X, Khan S. and S. J. E. o. o. t. t. Safe, \u201cTargeting NR4A1 (TR3) in cancer cells and tumors,\u201c vol.\u00a015, no. 2, pp.\u00a0195\u2013206, 2011.","DOI":"10.1517\/14728222.2011.547481"},{"issue":"4","key":"3031_CR88","first-page":"867","volume":"3","author":"B Biersack","year":"2020","unstructured":"Biersack B. 3,3\u2019-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs. Cancer Drug Resistance. 2020;3(4):867.","journal-title":"Cancer Drug Resistance"},{"issue":"4","key":"3031_CR89","doi-asserted-by":"publisher","first-page":"e1900028","DOI":"10.1002\/cbdv.201900028","volume":"16","author":"A Ahmad","year":"2019","unstructured":"Ahmad A, et al. Pentafluorophenyl Substitution of Natural Di (indol-3\u2010yl) methane strongly enhances growth inhibition and apoptosis induction in various Cancer cell lines. Chem Biodivers. 2019;16(4):e1900028.","journal-title":"Chem Biodivers"},{"key":"3031_CR90","first-page":"101492","volume":"35","author":"AS Baez-Gonzalez","year":"2023","unstructured":"Baez-Gonzalez AS, Carrazco-Carrillo JA, Figueroa-Gonzalez G, Quintas-Granados LI, Padilla-Benavides T, Reyes-Hernandez OD. Functional effect of indole-3 carbinol in the viability and invasive properties of cultured cancer cells. Biochem Biophys Rep. 2023;35:101492.","journal-title":"Biochem Biophys Rep"},{"key":"3031_CR91","unstructured":"Heath EI et al. \u201cA phase I dose-escalation study of oral BR-DIM (BioResponse 3,3\u2032-Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer,\u201c vol.\u00a02, no. 4, p.\u00a0402, 2010."},{"key":"3031_CR92","doi-asserted-by":"crossref","unstructured":"D\u00edaz-D\u00edaz CJ et al. \u201cThe aryl hydrocarbon receptor is a repressor of inflammation-associated colorectal tumorigenesis in mouse,\u201c vol. 264, no. 3, pp. 429\u201336, 2016.","DOI":"10.1097\/SLA.0000000000001874"},{"key":"3031_CR93","doi-asserted-by":"publisher","unstructured":"Kawajiri K et al. \u201cAryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin\/+ mice with natural ligands,\u201c (in eng), Proc Natl Acad Sci U S A, vol.\u00a0106, no. 32, pp.\u00a013481-6, Aug 11 2009. https:\/\/doi.org\/10.1073\/pnas.0902132106.","DOI":"10.1073\/pnas.0902132106"},{"key":"3031_CR94","doi-asserted-by":"publisher","unstructured":"Sanderson JT, Slobbe L, Lansbergen GWA, Safe S, van den Berg M. \u201c2,3,7,8-Tetrachlorodibenzo-p-dioxin and Diindolylmethanes Differentially Induce Cytochrome P450 1A1, 1B1, and 19 in H295R Human Adrenocortical Carcinoma Cells,\u201c Toxicological Sciences, vol. 61, no. 1, pp. 40\u20138, 2001. https:\/\/doi.org\/10.1093\/toxsci\/61.1.40%JToxicologicalSciences.","DOI":"10.1093\/toxsci\/61.1.40%JToxicologicalSciences"},{"key":"3031_CR95","doi-asserted-by":"crossref","unstructured":"Del Priore G, Gudipudi DK, Montemarano N, Restivo AM, Malanowska-Stega J. and A. A. J. G. o. Arslan, \u201cOral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia,\u201c vol.\u00a0116, no. 3, pp.\u00a0464\u2013467, 2010.","DOI":"10.1016\/j.ygyno.2009.10.060"},{"key":"3031_CR96","doi-asserted-by":"crossref","unstructured":"Bhowmik A et al. \u201c2,2\u2032-diphenyl-3,3\u2032-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway,\u201c vol. 8, no. 3, p. e59798, 2013.","DOI":"10.1371\/journal.pone.0059798"},{"key":"3031_CR97","doi-asserted-by":"crossref","unstructured":"Abdelbaqi K, Lack N, Guns ET, Kotha L, Safe S, Sanderson JTJTP. \u201cAntiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3\u2032\u2010diindolylmethane (Ring\u2010DIMs) in hormone\u2010responsive LNCaP human prostate cancer cells,\u201c vol. 71, no. 13, pp. 1401\u201312, 2011.","DOI":"10.1002\/pros.21356"},{"key":"3031_CR98","doi-asserted-by":"crossref","unstructured":"Goldberg AA, Titorenko VI, Beach A, Abdelbaqi K, Safe S. and J. T. J. I. n. d. Sanderson, \u201cRing-substituted analogs of 3,3\u2032-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and\u2013independent prostate cancer cells,\u201c vol. 32, no. 1, pp. 25\u201336, 2014.","DOI":"10.1007\/s10637-013-9979-y"},{"key":"3031_CR99","doi-asserted-by":"crossref","unstructured":"Draz H, Goldberg AA, Titorenko VI, Guns EST, Safe SH, Sanderson JTJCS. \u201cDiindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK),\u201c vol. 40, pp. 172\u201382, 2017.","DOI":"10.1016\/j.cellsig.2017.09.006"},{"key":"3031_CR100","doi-asserted-by":"crossref","unstructured":"Chintharlapalli S, Papineni S. and S. J. M. c. t. Safe, \u201c1, 1-Bis (3\u2032-indolyl)-1-(p-substituted phenyl) methanes inhibit colon cancer cell and tumor growth through PPAR\u03b3-dependent and PPAR\u03b3-independent pathways,\u201c vol.\u00a05, no. 5, pp.\u00a01362\u20131370, 2006.","DOI":"10.1158\/1535-7163.MCT-06-0002"},{"key":"3031_CR101","doi-asserted-by":"crossref","unstructured":"Lei P, Abdelrahim M, Cho SD, Liu S, Chintharlapalli S, Safe SJC. \u201c1, 1-Bis (3\u2032-indolyl)-1-(p-substituted phenyl) methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase,\u201c vol. 29, no. 6, pp. 1139\u201347, 2008.","DOI":"10.1093\/carcin\/bgn103"},{"key":"3031_CR102","doi-asserted-by":"crossref","unstructured":"Cooney AJ, Tsai SY, O\u2019Malley BW, Tsai MJM. and c. biology, \u201cChicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone, and retinoic acid receptors,\u201c vol.\u00a012, no. 9, pp.\u00a04153\u20134163, 1992.","DOI":"10.1128\/MCB.12.9.4153"},{"key":"3031_CR103","doi-asserted-by":"crossref","unstructured":"Le Dily F et al. \u201cCOUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells,\u201c vol. 110, no. 1, pp. 69\u201383, 2008.","DOI":"10.1007\/s10549-007-9693-6"},{"key":"3031_CR104","doi-asserted-by":"crossref","unstructured":"Cho SD et al. \u201c1, 1-bis (3\u2032\u2010indolyl)\u20101\u2010(p\u2010methoxyphenyl) methane activates Nur77\u2010independent proapoptotic responses in colon cancer cells,\u201c vol. 47, no. 4, pp. 252\u201363, 2008.","DOI":"10.1002\/mc.20378"},{"key":"3031_CR105","doi-asserted-by":"crossref","unstructured":"Yoon K, Lee S-O, Cho S-D, Kim K, Khan S, Safe SJC. \u201cActivation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors,\u201c vol. 32, no. 6, pp. 836\u201342, 2011.","DOI":"10.1093\/carcin\/bgr040"},{"key":"3031_CR106","doi-asserted-by":"crossref","unstructured":"Hedrick E et al. \u201cPotent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists,\u201c vol. 177, no. 1, pp. 29\u201340, 2019.","DOI":"10.1007\/s10549-019-05279-9"},{"key":"3031_CR107","doi-asserted-by":"crossref","unstructured":"Li X, Tjalkens RB, Shrestha R. S. J. C. b. Safe, and d. design, \u201cStructure-dependent activation of gene expression by bis\u2010indole and quinoline\u2010derived activators of nuclear receptor 4A2,\u201c vol.\u00a094, no. 4, pp.\u00a01711\u20131720, 2019.","DOI":"10.1111\/cbdd.13564"},{"key":"3031_CR108","doi-asserted-by":"crossref","unstructured":"Abdelrahim M, Newman K, Vanderlaag K, Samudio I, Safe SJC. \u201c3,3\u2032-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5,\u201c vol. 27, no. 4, pp. 717\u201328, 2006.","DOI":"10.1093\/carcin\/bgi270"},{"key":"3031_CR109","doi-asserted-by":"crossref","unstructured":"Boakye CH et al. \u201cLipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation,\u201c vol. 6, no. 5, pp. 526\u201339, 2016.","DOI":"10.1007\/s13346-016-0302-2"},{"key":"3031_CR110","doi-asserted-by":"crossref","unstructured":"Dankhoff K, Ahmad A, Weber B, Biersack B. and R. J. J. o. I. B. Schobert, \u201cAnticancer properties of a new non-oxido vanadium (IV) complex with a catechol-modified 3,3\u2032-diindolylmethane ligand,\u201c vol.\u00a0194, pp.\u00a01\u20136, 2019.","DOI":"10.1016\/j.jinorgbio.2019.02.005"},{"key":"3031_CR111","doi-asserted-by":"crossref","unstructured":"Chakraborty S et al. \u201cPhemindole, a synthetic di-indole derivative maneuvers the store operated calcium entry (SOCE) to induce potent anti-carcinogenic activity in human triple negative breast cancer cells,\u201c vol. 7, p. 114, 2016.","DOI":"10.3389\/fphar.2016.00114"},{"key":"3031_CR112","doi-asserted-by":"crossref","unstructured":"Sharma DK et al. \u201cDesign and synthesis of novel N, N\u2032-glycoside derivatives of 3,3\u2032-diindolylmethanes as potential antiproliferative agents,\u201c vol. 3, no. 9, pp. 1082\u201391, 2012.","DOI":"10.1039\/c2md20098h"},{"key":"3031_CR113","doi-asserted-by":"crossref","unstructured":"Cho SD et al. \u201c5, 5\u2032-Dibromo-bis (3\u2032-indolyl) methane induces Kruppel-like factor 4 and p21 in colon cancer cells,\u201c vol. 7, no. 7, pp. 2109\u201320, 2008.","DOI":"10.1158\/1535-7163.MCT-07-2311"},{"key":"3031_CR114","doi-asserted-by":"crossref","unstructured":"Choi K-H et al. \u201cThe p38 MAPK pathway is critical for 5, 5\u2032-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells,\u201c vol. 19, no. 2, pp. 153\u20139, 2010.","DOI":"10.1097\/CEJ.0b013e328333d088"},{"key":"3031_CR115","doi-asserted-by":"crossref","unstructured":"S. M. J. I. j. o. m. s. Kim, \u201cCellular and molecular mechanisms of 3,3\u2032-diindolylmethane in gastrointestinal cancer,\u201c vol.\u00a017, no. 7, p.\u00a01155, 2016.","DOI":"10.3390\/ijms17071155"},{"key":"3031_CR116","doi-asserted-by":"crossref","unstructured":"Chang X et al. \u201c3,3\u2032-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice,\u201c vol. 26, no. 4, pp. 771\u20138, 2005.","DOI":"10.1093\/carcin\/bgi018"},{"key":"3031_CR117","doi-asserted-by":"crossref","unstructured":"Zhang WW, Feng Z, J. J. o. SA, Narod BR. \u201cMultiple therapeutic and preventive effects of 3,3\u2032-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia,\u201c vol. 28, no. 5, p. 339, 2014.","DOI":"10.7555\/JBR.28.20140008"},{"key":"3031_CR118","doi-asserted-by":"crossref","unstructured":"Li W-X, Chen L-P, Sun M-Y, Li J-T, Liu H-Z, Zhu WJO. \u201c3\u2032 3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling,\u201c vol.\u00a06, no. 27, p.\u00a023776, 2015.","DOI":"10.18632\/oncotarget.4196"},{"key":"3031_CR119","doi-asserted-by":"crossref","unstructured":"Shin J-A et al. \u201cChemopreventive effects of synthetic C-substituted diindolylmethanes originating from cruciferous vegetables in human oral cancer cells,\u201c vol. 20, no. 5, pp. 417\u201325, 2011.","DOI":"10.1097\/CEJ.0b013e32834473c3"},{"issue":"3","key":"3031_CR120","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1021\/tx050325z","volume":"19","author":"RE Staub","year":"2006","unstructured":"Staub RE, Onisko B, Bjeldanes LF. Fate of 3,3 \u2018-Diindolylmethane in cultured MCF-7 human breast Cancer cells. Chem Res Toxicol. 2006;19(3):436\u201342.","journal-title":"Chem Res Toxicol"},{"key":"3031_CR121","doi-asserted-by":"crossref","unstructured":"Kim SJ, Lee J-S, Kim SMJOr. \u201c3,3\u2019-Diindolylmethane suppresses growth of human esophageal squamous cancer cells by G1 cell cycle arrest,\u201c vol. 27, no. 5, pp. 1669\u201373, 2012.","DOI":"10.3892\/or.2012.1662"},{"key":"3031_CR122","doi-asserted-by":"crossref","unstructured":"Li XJ, Park ES, Park MH, Kim SMJOr. \u201c3,3\u2019-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway,\u201c vol. 30, no. 5, pp. 2419\u201326, 2013.","DOI":"10.3892\/or.2013.2717"},{"key":"3031_CR123","doi-asserted-by":"crossref","unstructured":"Gao X, Liu J, Cho KB, Kedika S, Guo B. \u201cChemopreventive Agent 3,3\u2032-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells,\u201c vol.\u00a021, no. 13, p.\u00a04642, 2020.","DOI":"10.3390\/ijms21134642"},{"key":"3031_CR124","doi-asserted-by":"crossref","unstructured":"Du H et al. \u201cA novel phytochemical, DIM, inhibits proliferation, migration, invasion and TNF-\u03b1 induced inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients by targeting MAPK and AKT\/mTOR signal pathway,\u201c vol. 10, p. 1620, 2019.","DOI":"10.3389\/fimmu.2019.01620"},{"key":"3031_CR125","doi-asserted-by":"crossref","unstructured":"Banerjee S, Kong D, Wang Z, Bao B, Hillman GG. and F. H. J. M. R. R. i. M. R. Sarkar, \u201cAttenuation of multi-targeted proliferation-linked signaling by 3,3\u2032-diindolylmethane (DIM): from bench to clinic,\u201c vol.\u00a0728, no. 1\u20132, pp.\u00a047\u201366, 2011.","DOI":"10.1016\/j.mrrev.2011.06.001"},{"key":"3031_CR126","doi-asserted-by":"crossref","unstructured":"Chang X, Firestone GL, Bjeldanes LFJC. \u201cInhibition of growth factor-induced ras signaling in vascular endothelial cells and angiogenesis by 3,3\u2032-diindolylmethane,\u201c vol. 27, no. 3, pp. 541\u201350, 2006.","DOI":"10.1093\/carcin\/bgi230"},{"key":"3031_CR127","doi-asserted-by":"crossref","unstructured":"Cover CM et al. \u201cIndole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling,\u201c vol. 273, no. 7, pp. 3838\u201347, 1998.","DOI":"10.1074\/jbc.273.7.3838"},{"issue":"6939","key":"3031_CR128","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nature01606","volume":"423","author":"F Ohtake","year":"2003","unstructured":"Ohtake F, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature. 2003;423(6939):545\u201350.","journal-title":"Nature"},{"key":"3031_CR129","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1023\/A:1009550912337","volume":"5","author":"S Safe","year":"2000","unstructured":"Safe S, Wormke M, Samudio I. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J Mammary Gland Biol Neoplasia. 2000;5:295\u2013306.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"3031_CR130","doi-asserted-by":"crossref","unstructured":"Gillesby BE, Stanostefano M, Porter W, Safe S, Wu ZF, Zacharewski TR. \u201cIdentification of a motif within the 5 \u2018regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression,\u201c Biochemistry, vol.\u00a036, no. 20, pp.\u00a06080\u20136089, 1997.","DOI":"10.1021\/bi962131b"},{"issue":"4","key":"3031_CR131","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bcp.2008.09.039","volume":"77","author":"CM Vezina","year":"2009","unstructured":"Vezina CM, Lin T-M, Peterson RE. AHR signaling in prostate growth, morphogenesis, and disease. Biochem Pharmacol. 2009;77(4):566\u201376.","journal-title":"Biochem Pharmacol"},{"key":"3031_CR132","doi-asserted-by":"crossref","unstructured":"Schlezinger JJ et al. \u201cA role for the aryl hydrocarbon receptor in mammary gland tumorigenesis,\u201c 2006.","DOI":"10.1515\/BC.2006.145"},{"issue":"1","key":"3031_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kft128","volume":"135","author":"S Safe","year":"2013","unstructured":"Safe S, Lee S-O, Jin U-H. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicol Sci. 2013;135(1):1\u201316.","journal-title":"Toxicol Sci"},{"issue":"6","key":"3031_CR134","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1128\/MCB.23.6.1843-1855.2003","volume":"23","author":"M Wormke","year":"2003","unstructured":"Wormke M, et al. The aryl hydrocarbon receptor mediates degradation of estrogen receptor \u03b1 through activation of proteasomes. Mol Cell Biol. 2003;23(6):1843\u201355.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"3031_CR135","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/toxsci\/kfr300","volume":"125","author":"Z Madak-Erdogan","year":"2012","unstructured":"Madak-Erdogan Z, Katzenellenbogen BS. Aryl hydrocarbon receptor modulation of estrogen receptor \u03b1-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140. Toxicol Sci. 2012;125(2):401\u201311.","journal-title":"Toxicol Sci"},{"issue":"12","key":"3031_CR136","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrc3846","volume":"14","author":"IA Murray","year":"2014","unstructured":"Murray IA, Patterson AD, Perdew GH. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat Rev Cancer. 2014;14(12):801\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3031_CR137","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/15287399409531856","volume":"41","author":"DC Spink","year":"1994","unstructured":"Spink DC, Johnson JA, Connor SP, Aldous KM, Gierthy JF. Stimulation of 17\u03b2-estradiol metabolism in MCF\u20107 cells by bromochloro\u2010and chloromethyl\u2010substituted dibenzo\u2010p\u2010dioxins and dibenzofurans: correlations with antiestrogenic activity. J Toxicol Environ Health Part Curr Issues. 1994;41(4):451\u201366.","journal-title":"J Toxicol Environ Health Part Curr Issues"},{"issue":"4","key":"3031_CR138","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bcp.2008.08.034","volume":"77","author":"F Ohtake","year":"2009","unstructured":"Ohtake F, Fujii-Kuriyama Y, Kato S. AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem Pharmacol. 2009;77(4):474\u201384.","journal-title":"Biochem Pharmacol"},{"key":"3031_CR139","doi-asserted-by":"crossref","unstructured":"Swedenborg E, Pongratz I. \u201cAhR and ARNT modulate ER signaling,\u201c Toxicology, vol.\u00a0268, no. 3, pp.\u00a0132\u2013138, 2010.","DOI":"10.1016\/j.tox.2009.09.007"},{"key":"3031_CR140","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.toxrep.2014.09.016","volume":"1","author":"M G\u00f6ttel","year":"2014","unstructured":"G\u00f6ttel M, Le Corre L, Dumont C, Schrenk D, Chagnon M-C. Estrogen receptor \u03b1 and aryl hydrocarbon receptor cross-talk in a transfected hepatoma cell line (HepG2) exposed to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol Rep. 2014;1:1029\u201336.","journal-title":"Toxicol Rep"},{"issue":"5","key":"3031_CR141","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/ijms19051388","volume":"19","author":"S Narasimhan","year":"2018","unstructured":"Narasimhan S, et al. Towards resolving the pro-and anti-tumor effects of the aryl hydrocarbon receptor. Int J Mol Sci. 2018;19(5):1388.","journal-title":"Int J Mol Sci"},{"key":"3031_CR142","doi-asserted-by":"crossref","unstructured":"Marconett CN, Sundar SN, Poindexter KM, Stueve TR, Bjeldanes LF. and G. L. J. M. b. o. t. c. Firestone, \u201cIndole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER) \u03b1 protein degradation in breast cancer cells disrupting an ER\u03b1-GATA3 transcriptional cross-regulatory loop,\u201c vol.\u00a021, no. 7, pp.\u00a01166\u20131177, 2010.","DOI":"10.1091\/mbc.e09-08-0689"},{"key":"3031_CR143","doi-asserted-by":"crossref","unstructured":"Arellano-Guti\u00e9rrez CV et al. \u201cIndole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest,\u201c vol. 44, no. 5, pp. 2054\u201368, 2022.","DOI":"10.3390\/cimb44050139"},{"key":"3031_CR144","doi-asserted-by":"crossref","unstructured":"Qi M, Anderson AE, Chen D-Z, Sun S, Auborn KJ. Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo. Mol Med. 2005;11(1):59\u201363.","DOI":"10.2119\/2006-00007.Auborn"},{"key":"3031_CR145","doi-asserted-by":"crossref","unstructured":"Tamura M, Gu J, Matsumoto K, Aota S-i, Parsons R, Yamada KMJS. \u201cInhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN,\u201c vol.\u00a0280, no. 5369, pp.\u00a01614\u20131617, 1998.","DOI":"10.1126\/science.280.5369.1614"},{"key":"3031_CR146","doi-asserted-by":"crossref","unstructured":"Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA. and J. J. J. A. j. o. c. p. Isola, \u201cReduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer,\u201c vol.\u00a0105, no. 4, pp.\u00a0394\u2013402, 1996.","DOI":"10.1093\/ajcp\/105.4.394"},{"key":"3031_CR147","doi-asserted-by":"crossref","unstructured":"Handschuh G et al. \u201cTumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility,\u201c vol. 18, no. 30, pp. 4301\u201312, 1999.","DOI":"10.1038\/sj.onc.1202790"},{"key":"3031_CR148","doi-asserted-by":"crossref","unstructured":"Ho J-N, Jun W, Choue R, Lee JJMMR. \u201cI3C and ICZ inhibit migration by suppressing the EMT process and FAK expression in breast cancer cells,\u201c vol. 7, no. 2, pp. 384\u20138, 2013.","DOI":"10.3892\/mmr.2012.1198"},{"key":"3031_CR149","doi-asserted-by":"crossref","unstructured":"Pani S, Sahoo A, Patra A, Debata PRJB, Biochemistry A. \u201cPhytocompounds curcumin, quercetin, indole-3\u2010carbinol, and resveratrol modulate lactate\u2013pyruvate level along with cytotoxic activity in HeLa cervical cancer cells,\u201c vol. 68, no. 6, pp. 1396\u2013402, 2021.","DOI":"10.1002\/bab.2061"},{"key":"3031_CR150","doi-asserted-by":"publisher","unstructured":"Munakarmi S, Shrestha J, Shin H-B, Lee G-H, Jeong Y-J. \u201c3,3\u2032-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis,\u201c Cells, vol.\u00a010, no. 5, p.\u00a01178, 2021. https:\/\/doi.org\/10.3390\/cells10051178.","DOI":"10.3390\/cells10051178"},{"issue":"5","key":"3031_CR151","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.7150\/ijbs.56833","volume":"17","author":"Y Ye","year":"2021","unstructured":"Ye Y, et al. 3,3\u2019-Diindolylmethane induces gastric cancer cells death via STIM1 mediated store-operated calcium entry. Int J Biol Sci. 2021;17(5):1217\u201333. https:\/\/doi.org\/10.7150\/ijbs.56833.","journal-title":"Int J Biol Sci"},{"key":"3031_CR152","doi-asserted-by":"crossref","unstructured":"Ye F et al. (2020) Inhibition of endogenous hydrogen sulfide biosynthesis enhances the anti- cancer effect of 3,3\u2032-diindolylmethane in human gastric cancer cells. Life Science. Available: https:\/\/www-sciencedirect-com.pbidi.unam.mx:2443\/science\/article\/pii\/S0024320520311000.","DOI":"10.1016\/j.lfs.2020.118348"},{"key":"3031_CR153","doi-asserted-by":"publisher","unstructured":"Zhu P, Yu H, Zhou K, Bai Y, Qi R, Zhang S. 3,3\u2032-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA\/ROCK1-mediated COX2\/PGE2 pathway. J Experimental Clin Cancer Res. 2020;39(1). https:\/\/doi.org\/10.1186\/s13046-020-01618-7.","DOI":"10.1186\/s13046-020-01618-7"},{"key":"3031_CR154","doi-asserted-by":"publisher","unstructured":"Lee J. (2019) 3,3\u2032-Diindolylmethane Inhibits TNF-\u03b1- and TGF-\u03b2-Induced Epithelial\u2013Mesenchymal Transition in Breast Cancer Cells. Nutrition and Cancer. 992\u20131006. Available: https:\/\/www-tandfonline-com.pbidi.unamhttps:\/\/doi.org\/10.1080\/01635581.2019.1577979.","DOI":"10.1080\/01635581.2019.1577979"},{"key":"3031_CR155","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2019.01.031","volume":"448","author":"X Tian","year":"2019","unstructured":"Tian X, et al. 3,3\u2019-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1\/2 and ERK1\/2. Cancer Lett. 2019;448:20\u201330. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.031.","journal-title":"Cancer Lett"},{"key":"3031_CR156","doi-asserted-by":"crossref","unstructured":"Heo JR, Lee G-A, Kim GS, Hwang K-A, Choi KC. \u201cPhytochemical-induced reactive oxygen species and endoplasmic reticulum stress-mediated apoptosis and differentiation in malignant melanoma cells \" vol. 39, pp. 100\u201310, 2018.","DOI":"10.1016\/j.phymed.2017.12.006"},{"key":"3031_CR157","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.63743","author":"M Kapa\u0142czy\u0144ska","year":"2016","unstructured":"Kapa\u0142czy\u0144ska M, et al. 2D and 3D cell cultures \u2013 a comparison of different types of cancer cell cultures. Archives of Medical Science. 2016. https:\/\/doi.org\/10.5114\/aoms.2016.63743.","journal-title":"Archives of Medical Science"},{"key":"3031_CR158","doi-asserted-by":"publisher","unstructured":"Xu J, Qi G, Wang W, Sun XS. Advances in 3D peptide hydrogel models in cancer research. npj Sci Food. 2021;5(1). https:\/\/doi.org\/10.1038\/s41538-021-00096-1.","DOI":"10.1038\/s41538-021-00096-1"},{"key":"3031_CR159","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fonc.2019.00077","volume":"9","author":"RN Njoroge","year":"2019","unstructured":"Njoroge RN, Vatapalli RJ, Abdulkadir SA. Organoids increase the predictive value of,\u201c (in eng). Front Oncol. 2019;9:77. https:\/\/doi.org\/10.3389\/fonc.2019.00077.","journal-title":"Front Oncol"},{"key":"3031_CR160","doi-asserted-by":"publisher","unstructured":"Benham V, et al. Identifying chemopreventive agents for obesity-associated cancers using an efficient, 3D high-throughput transformation assay. Sci Rep. 2019;9(1). https:\/\/doi.org\/10.1038\/s41598-019-46531-y.","DOI":"10.1038\/s41598-019-46531-y"},{"key":"3031_CR161","doi-asserted-by":"publisher","unstructured":"Breslin S, O\u2019Driscoll L. \u201cThe relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance,\u201c Oncotarget, vol.\u00a07, no. 29, pp.\u00a045745\u201345756, 2016. https:\/\/doi.org\/10.18632\/oncotarget.9935.","DOI":"10.18632\/oncotarget.9935"},{"key":"3031_CR162","doi-asserted-by":"publisher","unstructured":"Tung YC, Hsiao AY, Allen SG, Torisawa YS, Ho M, Takayama S. \u201cHigh-throughput 3D spheroid culture and drug testing using a 384 hanging drop array,\u201c (in eng), Analyst, vol.\u00a0136, no. 3, pp.\u00a0473-8, Feb 07 2011. https:\/\/doi.org\/10.1039\/c0an00609b.","DOI":"10.1039\/c0an00609b"},{"key":"3031_CR163","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.drup.2013.05.001","volume":"16","author":"M Garofalo","year":"2013","unstructured":"Garofalo M, Croce CM. MicroRNAs as therapeutic targets in chemoresistance. Drug Resist Updates. 2013;16:3\u20135. https:\/\/doi.org\/10.1016\/j.drup.2013.05.001.","journal-title":"Drug Resist Updates"},{"key":"3031_CR164","doi-asserted-by":"publisher","unstructured":"Nikulin SV et al. \u201cBreast cancer organoid model allowed to reveal potentially beneficial combinations of 3,3\u2032-diindolylmethane and chemotherapy drugs,\u201c Biochimie, vol.\u00a0179, no. 217\u2013227, 2020. https:\/\/doi.org\/10.1016\/j.biochi.2020.10.007.","DOI":"10.1016\/j.biochi.2020.10.007"},{"key":"3031_CR165","doi-asserted-by":"publisher","unstructured":"Miermont A, Lee SWL, Adriani G, Kamm RD. Quantitative screening of the effects of hyper-osmotic stress on cancer cells cultured in 2- or 3-dimensional settings. Sci Rep. 2019;9(1). https:\/\/doi.org\/10.1038\/s41598-019-50198-w.","DOI":"10.1038\/s41598-019-50198-w"},{"issue":"4","key":"3031_CR166","doi-asserted-by":"publisher","first-page":"045010","DOI":"10.1088\/2057-1976\/aac1c9","volume":"4","author":"JM Rios De La Rosa","year":"2018","unstructured":"Rios De La Rosa JM, Wubetu J, Tirelli N, Tirella A. Colorectal tumor 3D in vitro models: advantages of biofabrication for the recapitulation of early stages of tumour development. Biomed Phys Eng Express. 2018;4(4):045010. https:\/\/doi.org\/10.1088\/2057-1976\/aac1c9.","journal-title":"Biomed Phys Eng Express"},{"key":"3031_CR167","doi-asserted-by":"publisher","unstructured":"Katt ME, Placone AL, Wong AD, Xu ZS, S PC. earson. (2016) In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform. Frontiers in Bioengineering and Biotechnology. Available: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fbioe.2016.00012\/full.","DOI":"10.3389\/fbioe.2016.00012\/full"},{"key":"3031_CR168","doi-asserted-by":"crossref","unstructured":"Jensen C, Shay C, Teng Y. The New Frontier of Three-Dimensional Culture Models to Scale-Up. Springer US; 2022. pp. 3\u201318.","DOI":"10.1007\/978-1-0716-1558-4_1"},{"key":"3031_CR169","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.procbio.2018.12.028","volume":"78","author":"Xi Xin","year":"2019","unstructured":"Xin Xi, Yang, Hopen F, Zhang, Yang S-T. 3D cell coculture tumor model: a promising approach for future cancer drug discovery. Process Biochem. 2019;78:148\u201360. https:\/\/doi.org\/10.1016\/j.procbio.2018.12.028.","journal-title":"Process Biochem"},{"key":"3031_CR170","doi-asserted-by":"publisher","unstructured":"Datta P, Dey M, Ataie Z, Unutmaz D, Ozbolat IT. 3D bioprinting for reconstituting the cancer microenvironment. npj Precision Oncology. 2020;4(1). https:\/\/doi.org\/10.1038\/s41698-020-0121-2.","DOI":"10.1038\/s41698-020-0121-2"},{"key":"3031_CR171","doi-asserted-by":"publisher","unstructured":"Martinez-Pacheco S, O\u2019Driscoll L. Pre-clinical in vitro models used in cancer research: results of a worldwide survey. Cancers. 2021;13(23):6033. https:\/\/doi.org\/10.3390\/cancers13236033.","DOI":"10.3390\/cancers13236033"},{"key":"3031_CR172","doi-asserted-by":"publisher","unstructured":"Reed GA, et al. Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3\u2019-diindolylmethane in healthy subjects,\u201c (in eng). Cancer Epidemiol Biomarkers Prev. Oct 2008;17(10):2619\u201324. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0520.","DOI":"10.1158\/1055-9965.EPI-08-0520"},{"key":"3031_CR173","doi-asserted-by":"publisher","unstructured":"Leibelt DA, Hedstrom OR, Fischer KA, Pereira CB, Williams DE. Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3\u2019-diindolylmethane in sprague-dawley rats,\u201c (in eng). Toxicol Sci. Jul 2003;74(1):10\u201321. https:\/\/doi.org\/10.1093\/toxsci\/kfg103.","DOI":"10.1093\/toxsci\/kfg103"},{"key":"3031_CR174","doi-asserted-by":"publisher","unstructured":"Elackattu AP, Feng L, Wang Z. \u201cA controlled safety study of diindolylmethane in the immature rat model,\u201c (in eng), Laryngoscope, vol.\u00a0119, no. 9, pp.\u00a01803-8, Sep 2009. https:\/\/doi.org\/10.1002\/lary.20526.","DOI":"10.1002\/lary.20526"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-023-03031-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-023-03031-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-023-03031-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:25:54Z","timestamp":1700285154000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-023-03031-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":174,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3031"],"URL":"https:\/\/doi.org\/10.1186\/s12935-023-03031-4","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors wish to confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}